1. Burt MG, Morey AL, Turner JJ, Pell M, Sheehy JP, Ho KK. Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary. 2003; 6:161–168.
2. Cheung CC, Ezzat S, Smyth HS, Asa SL. The spectrum and significance of primary hypophysitis. J Clin Endocrinol Metab. 2001; 86:1048–1053.
3. Folkerth RD, Price DL Jr, Schwartz M, Black PM, De Girolami U. Xanthomatous hypophysitis. Am J Surg Pathol. 1998; 22:736–741.
4. Bonneville F, Cattin F, Marsot-Dupuch K, Dormont D, Bonneville JF, Chiras J. T1 Signal hyperintensity in the sellar region: spectrum of findings. Radiographics. 2006; 26:93–113.
5. Bullmann C, Faust M, Hoffmann A, Heppner C, Jockenhovel F, Muller Wieland D, et al. Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis. Eur J Endocrinol. 2000; 142:365–372.
6. Kelly WF, Bradey N, Scoones D. Rosai-Dorfman disease presenting as a pituitary tumour. Clin Endocrinol (Oxf). 1999; 50:133–137.
7. Paulus W, Honegger J, Keyvani K, Fahlbusch R. Xanthogranuloma of the sellar region; a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol. 1999; 97:377–382.
8. Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer. 2001; 8:287–305.
9. Gutenberg A, Hans V, Puchner MJ, Kreutzer J, Brück W, Caturegli P, et al. Primary hypophysitis: clinical-pathological correlations. Eur J Endocrinol. 2006; 155:101–107.